Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04046445
Title Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer (KISIMA-01)
Acronym KISIMA-01
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Amal Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | DEU | CHE | BEL

Facility Status City State Zip Country Details
Honor Health Institute Scottsdale Arizona 85258 United States Details
University of Southern California Los Angeles California 90033 United States Details
University of Colorado Anschutz Medical Campus Aurora Colorado 80045 United States Details
NYU Langone Health New York New York 10016 United States Details
Weill Cornell Medicine New York New York 10065 United States Details
Duke Cancer Institute Durham North Carolina 27710 United States Details
University of Texas, MD Anderson Cancer Center Houston Texas 77030 United States Details
University Hospital Antwerpen Edegem 2650 Belgium Details
University Hospital Leuven Leuven 3000 Belgium Details
University Medicine Mainz Mainz 55131 Germany Details
University Hospital Zurich Zürich Zurich 8006 Switzerland Details
Geneva University Hospitals Geneva 1205 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field